E-Cigarette Use Tied to Respiratory Symptoms, Wheezing

FRIDAY, Feb. 18, 2022 (HealthDay News) -- Former and current electronic cigarette use is associated with higher odds of developing wheezing-related respiratory symptoms, according to a study published online Jan. 27 in the American Journal of Respiratory and Critical Care Medicine.
Wubin Xie, Dr.P.H., from the Boston University School of Public Health, and colleagues assessed whether e-cigarette use is associated with the development of respiratory symptoms in young adults. The analysis included young adult participants (aged 18 to 24 years at baseline) in the Population Assessment of Tobacco and Health Study Waves 2 (2014-2015), 3 (2015-2016), 4 (2016-2018), and 5 (2018-2019).
The researchers found that former e-cigarette use was associated with higher odds of developing any respiratory symptom (adjusted odds ratio [aOR], 1.20), as well as wheezing in the chest (aOR, 1.41). Similar associations were seen for current e-cigarette use and higher odds for any respiratory symptom (aOR, 1.32) and wheezing in the chest (aOR, 1.51). These associations persisted even among participants who never smoked combustible cigarettes.
"The present study finds a significant prospective association of vaping with subsequent respiratory symptom development in a large, nationally representative cohort of young adults with no previous history of respiratory symptoms," a coauthor said in a statement. "This evidence highlights an urgent public health imperative for more robust regulatory standards at all levels of government to stop the youth vaping epidemic in its tracks."
Abstract/Full Text (subscription or payment may be required)
Related Posts
FDA Approves Imaging Drug That Can Help Surgeons Spot Ovarian Cancers
MONDAY, Nov. 29, 2021 (HealthDay News) -- Early detection of ovarian cancer...
Los CDC relajan las normas sobre la vacunación contra la COVID para los viajeros extranjeros
VIERNES, 28 de abril de 2023 (HealthDay News) -- Los viajeros a Estados Unidos...
FDA Approves Dupixent for Prurigo Nodularis
FRIDAY, Sept. 30, 2022 (HealthDay News) -- The U.S. Food and Drug Administration...
Pfizer Begins Testing a COVID Vaccine Targeted to Omicron
TUESDAY, Jan. 25, 2022 (HealthDay News) -- Pfizer Inc. announced Tuesday that it...
